Search
- Cost Estimate
As ordered reported by the House Committee on Ways and Means on September 5, 2018
- Cost Estimate
As ordered reported by the House Committee on Ways and Means on September 5, 2018
- Cost Estimate
As ordered reported by the House Committee on Ways and Means on September 5, 2018
- Blog Post
CBO Director Keith Hall announces the members of a new technical review panel that will provide feedback on the next generation of CBO’s health insurance simulation model, which is being developed and tested.
- Cost Estimate
As passed by the House of Representatives on May 22, 2018
- Report
CBO presents information on enrollment in and spending for Medicaid managed care and analyzes factors affecting those measures—including the types of beneficiaries, geographic areas, and range of services that managed care programs cover.
- Blog Post
CBO and its analyses benefit from the advisers’ understanding of cutting-edge research and the latest developments in health care delivery and financing.
- Report
The House Budget Committee convened a hearing at which Director Keith Hall testified about The Budget and Economic Outlook: 2018 to 2028. This document provides CBO’s answers to questions submitted for the record by Congressman Palmer.
- Cost Estimate
As ordered reported by the House Committee on Ways and Means on June 21, 2018
- Report
In a letter to Congressman Mark Meadows, CBO explains its estimate for section 53116 of the Bipartisan Budget Act requiring brand-name prescription drug manufacturers to increase the discount offered to some Medicare Part D beneficiaries.